🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 02/12/1992 | 0,1193 USD |
| 31/08/1992 | 0,1193 USD |
| 02/06/1992 | 0,1097 USD |
| 02/03/1992 | 0,1097 USD |
| 02/12/1991 | 0,1002 USD |
| 30/08/1991 | 0,1002 USD |
| 03/06/1991 | 0,0891 USD |
| 04/03/1991 | 0,0891 USD |
| 03/12/1990 | 0,0891 USD |
| 28/08/1990 | 0,0891 USD |
| 29/05/1990 | 0,0716 USD |
| 05/03/1990 | 0,0716 USD |
| 04/12/1989 | 0,0716 USD |
| 29/08/1989 | 0,0716 USD |
| 30/05/1989 | 0,0652 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 24/06/2002 | 46,80 | 47,71 | 45,42 | 47,23 | -0,96% | 4,89% | 14.096.438 |
| 21/06/2002 | 47,95 | 48,86 | 47,47 | 47,69 | -4,25% | 2,89% | 16.015.746 |
| 20/06/2002 | 49,67 | 50,16 | 49,62 | 49,81 | -0,65% | 1,10% | 4.860.729 |
| 19/06/2002 | 50,11 | 51,05 | 49,91 | 50,13 | -0,79% | 2,27% | 5.440.482 |
| 18/06/2002 | 50,83 | 51,14 | 50,47 | 50,53 | -0,77% | 1,31% | 4.312.520 |
| 17/06/2002 | 50,11 | 51,40 | 49,72 | 50,93 | +1,64% | 3,35% | 5.623.254 |
| 14/06/2002 | 49,62 | 50,28 | 48,62 | 50,11 | +0,92% | 3,35% | 6.917.848 |
| 13/06/2002 | 49,43 | 50,67 | 48,83 | 49,65 | +0,08% | 3,73% | 7.312.001 |
| 12/06/2002 | 48,45 | 49,71 | 48,45 | 49,61 | +0,21% | 2,60% | 8.201.124 |
| 11/06/2002 | 50,95 | 51,53 | 49,26 | 49,50 | -4,46% | 4,46% | 9.967.842 |
| 10/06/2002 | 50,26 | 52,39 | 49,87 | 51,81 | +3,08% | 5,01% | 5.937.863 |
| 07/06/2002 | 49,86 | 50,72 | 49,63 | 50,27 | -0,98% | 2,18% | 10.016.889 |
| 06/06/2002 | 51,77 | 51,77 | 50,00 | 50,76 | -3,18% | 3,43% | 8.871.110 |
| 05/06/2002 | 52,43 | 52,47 | 51,58 | 52,43 | +0,55% | 1,69% | 4.803.718 |
| 04/06/2002 | 52,69 | 52,71 | 51,76 | 52,15 | -1,03% | 1,81% | 6.162.345 |
| 03/06/2002 | 54,44 | 54,57 | 52,53 | 52,69 | -3,29% | 3,75% | 5.310.740 |
| 31/05/2002 | 54,25 | 54,72 | 53,94 | 54,48 | +1,26% | 1,44% | 7.080.812 |
| 30/05/2002 | 53,82 | 54,51 | 53,53 | 53,81 | -1,30% | 1,83% | 4.531.447 |
| 29/05/2002 | 53,47 | 54,58 | 53,39 | 54,51 | +1,95% | 2,23% | 6.305.921 |
| 28/05/2002 | 53,91 | 54,03 | 53,39 | 53,47 | -0,80% | 1,19% | 4.641.592 |
| 24/05/2002 | 54,82 | 55,25 | 53,69 | 53,90 | -1,76% | 2,84% | 4.125.662 |
| 23/05/2002 | 54,66 | 54,91 | 53,91 | 54,87 | -0,03% | 1,83% | 5.864.084 |
| 22/05/2002 | 55,06 | 55,58 | 54,41 | 54,89 | -0,48% | 2,13% | 4.425.390 |
| 21/05/2002 | 55,54 | 55,86 | 54,89 | 55,15 | -0,69% | 1,75% | 5.210.237 |
| 20/05/2002 | 55,37 | 56,15 | 54,97 | 55,53 | +0,12% | 2,14% | 5.167.688 |
| 17/05/2002 | 54,01 | 55,58 | 53,96 | 55,47 | +2,70% | 3,00% | 6.409.673 |
| 16/05/2002 | 54,29 | 54,30 | 53,44 | 54,01 | -0,53% | 1,60% | 6.015.834 |
| 15/05/2002 | 54,48 | 54,81 | 53,82 | 54,29 | -1,04% | 1,82% | 5.616.756 |
| 14/05/2002 | 54,37 | 55,14 | 54,27 | 54,87 | +1,52% | 1,60% | 5.767.773 |
| 13/05/2002 | 53,43 | 54,19 | 53,32 | 54,05 | +1,85% | 1,63% | 4.385.146 |